A 2023 observational analysis published in the Annals of the Rheumatic Diseases found that patients with inflammatory arthritis who used GLP-1 receptor agonists had lower rates of cardiovascular events, which is notable because cardiovascular disease is a leading cause of death in RA patients
Hitting both pathways at the same time tends to produce stronger weight loss and stronger glucose control than activating GLP-1 alone, which is what the head-to-head trial data shows
* Disclaimer When ordering medications from Regen Doctors that require a prescription
Diabetic ketoacidosis In patients with insulindependent diabetes, the risk of DKA is the primary concern
The app keeps everything organized by date and dose, so when your doctor asks how you have been feeling, you're not just taking a guess
Rather, it simply announced that an activity lawful yesterday would be unlawful tomorrow